Save information for later
Sign Up

Learn About Adenine Phosphoribosyltransferase Deficiency

What is the definition of Adenine Phosphoribosyltransferase Deficiency?

Adenine phosphoribosyltransferase (APRT) deficiency is an inherited condition that affects the kidneys and urinary tract. The most common feature of this condition is recurrent kidney stones; urinary tract stones are also a frequent symptom. Kidney and urinary tract stones can create blockages in the urinary tract, causing pain during urination and difficulty releasing urine.

What are the causes of Adenine Phosphoribosyltransferase Deficiency?

Mutations in the APRT gene cause APRT deficiency. This gene provides instructions for making APRT, an enzyme that helps to convert a DNA building block (nucleotide) called adenine to a molecule called adenosine monophosphate (AMP). This conversion occurs when AMP is needed as a source of energy for cells.

How prevalent is Adenine Phosphoribosyltransferase Deficiency?

APRT deficiency is estimated to affect 1 in 27,000 people in Japan. The condition is rarer in Europe, where it is thought to affect 1 in 50,000 to 100,000 people. The prevalence of APRT deficiency outside these populations is unknown.

Is Adenine Phosphoribosyltransferase Deficiency an inherited disorder?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Who are the top Adenine Phosphoribosyltransferase Deficiency Local Doctors?
Elite in Adenine Phosphoribosyltransferase Deficiency
Elite in Adenine Phosphoribosyltransferase Deficiency
Reykjavik, IS 

Hrafnhildur Runolfsdottir practices in Reykjavik, Iceland. Runolfsdottir is rated as an Elite expert by MediFind in the treatment of Adenine Phosphoribosyltransferase Deficiency. Their top areas of expertise are Adenine Phosphoribosyltransferase Deficiency, Kidney Stones, Chronic Kidney Disease, Severe Acute Respiratory Syndrome (SARS), and Kidney Transplant.

Elite in Adenine Phosphoribosyltransferase Deficiency
Elite in Adenine Phosphoribosyltransferase Deficiency
Reykjavik, IS 

Vidar Edvardsson practices in Reykjavik, Iceland. Edvardsson is rated as an Elite expert by MediFind in the treatment of Adenine Phosphoribosyltransferase Deficiency. Their top areas of expertise are Adenine Phosphoribosyltransferase Deficiency, Kidney Stones, Nephrocalcinosis, Dent Disease, and Kidney Transplant.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Adenine Phosphoribosyltransferase Deficiency
Elite in Adenine Phosphoribosyltransferase Deficiency
Reykjavik, IS 

Runolfur Palsson practices in Reykjavik, Iceland. Palsson is rated as an Elite expert by MediFind in the treatment of Adenine Phosphoribosyltransferase Deficiency. Their top areas of expertise are Adenine Phosphoribosyltransferase Deficiency, Monoclonal Gammopathy of Undetermined Significance (MGUS), Kidney Stones, Kidney Transplant, and Heart Bypass Surgery.

What are the latest Adenine Phosphoribosyltransferase Deficiency Clinical Trials?
Prospective Study of the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders

Background: Pyrimidine and purine metabolism disorders (DPPMs) affect how the body metabolizes chemicals called pyrimidines and purines. DPPMs can cause dysfunctions throughout the body, especially in the brain, blood, kidneys, and immune system. People with DPPMs might have no symptoms, mild symptoms, or they may have severe, chronic symptoms, that can be fatal. DPPMs are not well understood, and researchers...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Prospective Research Rare Kidney Stones (ProRKS)

Summary: The purpose of this study is to determine the natural history of the hereditary forms of nephrolithiasis and chronic kidney disease (CKD), primary hyperoxaluria (PH), cystinuria, Dent disease and adenine phosphoribosyltransferase deficiency (APRTd) and acquired enteric hyperoxaluria (EH). The investigator will measure blood and urinary markers of inflammation and determine relationship to the dise...

Who are the sources who wrote this article ?

Published Date: October 01, 2012
Published By: National Institutes of Health